Opposing functions of gut immunomodulatory metabolites on CAR-T therapy
Gut microbial taxonomy alone is a poor predictor of CAR-T cell therapy outcome. Instead, specific gut immunomodulatory metabolites exert opposing effects on CAR-T cell function and tumor control, identifying microbial metabolism as a potential target to predict and improve CAR-T cell outcomes.